Physician profile

Alejandro Garza

Vascular Surgery · Mcallen, TX

NPI 1073990990

$29,916.01

in general payments reported to CMS, 2019-2025

26 companies · $2,409 in 2025

The $2,409 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$9,834.08
Travel and Lodging$8,052.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $11,048.55 2021-2024 Indigo System, Benchmark, Penumbra System
Silk Road Medical, INC. $3,579.68 2021-2023 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent
Medtronic, INC. $3,328.17 2021-2025 Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System
W. L. Gore & Associates, INC. $2,787.66 2020-2024 Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin
Cardiovascular Systems INC. $2,358.95 2022-2023 Diamondback Peripheral
Abbott Laboratories $1,081.57 2023-2025 Esprit, Diamondback Peripheral, Supera
Bard Peripheral Vascular, INC. $921.69 2022-2025 Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Set Aspirex S 10f 110cm
Tactile Systems Technology INC $718.45 2024-2025 Flexitouch Plus, Nimbl, Entre Plus
Endologix LLC $555.02 2022-2024 Endocross Device, Torus Stent Graft System
Medtronic Vascular, INC. $445.48 2020
Philips North America LLC $444.92 2022-2025 (Br5) Peripheral Ivus, Pv 018 Otw, Ds Zenition 70
Boston Scientific Corporation $427.84 2021-2025 General - Vascular Intervention, Opticross 35
Limflow INC. $348.21 2023 Limflow System
Stryker Corporation $338.99 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Inari Medical, INC. $334.86 2021-2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Show all 26 companies
CompanyGeneral paymentsYearsTop products
Reflow Medical INC $299.35 2025
Shockwave Medical, INC $256.97 2021-2022
Kerecis Limited $132.62 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide
Ethicon US, LLC $114.15 2024 Stratafix
Cook Medical LLC $97.65 2022
Imperative Care, INC $95.41 2023 Symphony Catheter
Terumo Medical Corporation $60.42 2024-2025 Angio-Seal, Metacross Otw
Janssen Pharmaceuticals, INC $57.28 2024 Xarelto
Bolton Medical INC $51.63 2023 Treo Abdominal Stent-Graft System
Lemaitre Vascular, INC. $16.72 2023 Xenosure Biologic Patch
Angiodynamics, INC. $13.77 2024 Auryon Laser System 100-120 Vac

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alejandro Garza

$29,916.01

in general payments reported 2019-2025

Years
2020-2025
Top company
Penumbra, INC.
Context
The $2,409 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/1351516/alejandro-garza

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.